Page last updated: 2024-08-17

cytidine triphosphate and Breast Cancer

cytidine triphosphate has been researched along with Breast Cancer in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Beijnen, JH; Derissen, EJB; Huitema, ADR; Rosing, H; Schellens, JHM1
Huang, M; Lewicki, P; Mitchell, BS; Whang, P1

Trials

1 trial(s) available for cytidine triphosphate and Breast Cancer

ArticleYear
Intracellular pharmacokinetics of gemcitabine, its deaminated metabolite 2',2'-difluorodeoxyuridine and their nucleotides.
    British journal of clinical pharmacology, 2018, Volume: 84, Issue:6

    Topics: Activation, Metabolic; Antimetabolites, Antineoplastic; Breast Neoplasms; Cytidine Triphosphate; Deamination; Deoxycytidine; Female; Floxuridine; Gemcitabine; Humans; Leukocytes, Mononuclear; Phosphorylation; Uridine Triphosphate

2018

Other Studies

1 other study(ies) available for cytidine triphosphate and Breast Cancer

ArticleYear
Cyclopentenyl cytosine induces senescence in breast cancer cells through the nucleolar stress response and activation of p53.
    Molecular pharmacology, 2011, Volume: 80, Issue:1

    Topics: Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Nucleolus; Cellular Senescence; Cyclin-Dependent Kinase Inhibitor p21; Cytidine; Cytidine Triphosphate; Female; Gene Silencing; Genes, p53; Histones; Humans; Immunohistochemistry; RNA, Small Interfering

2011